ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1222

Impact of Bariatric Surgery on Bone Mineral Density : Observational Study of 110 Patients Followed up in a Specialised Centre for the Treatment of Obesity in France

Marion Geoffroy1, Isabelle Lambrecht1, Jan Chrusciel2, Isabelle Gaubil-Kaladjian3, Ana Diaz-Cives4, Jean Paul Eschard1 and Jean-Hugues Salmon1, 1Service de Rhumatologie, CHU Reims, Hôpital Maison Blanche, Reims, France, 2Service de Recherche Clinique, CHU Reims, Hôpital Robert Debré, Reims, France, 3Service d’Endocrinologie et nutrition, CHU Reims, Hôpital Robert Debré, Reims, France, 4Service de chirurgie digestive, CHU Reims, Hôpital Robert Debré, Reims, France

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Bone density, Dual energy x-ray absorptiometry (DEXA), fractures and obesity

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Bariatric surgery is used to treat severe obesity. We aimed to investigate the incidence of significant bone mineral density (BMD) loss at 6 and 12 months after bariatric surgery.

Methods: Observational study performed in a specialised centre for the treatment of obesity in a University Hospital in France. Surface BMD was measured by dual x-ray absorptiometry (DEXA). A reduction of >0.03g/cm² was considered as significant.

Results: A total of 110 patients were included. A significant reduction in BMD was observed in 63.4% of patients at 6 months, and in 73.9% at 12 months after surgery. No case of osteoporosis was observed. There were 4 cases of osteopenia and one fracture post-surgery. BMD loss was related by univariate analysis to the reduction in Body Mass Index (BMI) (p<0,01), weight loss (p<0,01), fat mass (p<0,01) and lean mass (p<0,01). Multivariate analysis found a significant association between the reduction in BMD and the percent excess weight loss (odds ratio 1.11, 95% confidence interval (1.05-1.18), p<0.001).

Conclusion: There is a significant reduction in BMD at 6 months after surgery in over 60% of patients undergoing bariatric surgery. BMD loss is persistent over time, and predominantly situated at the femoral level, and strongly associated with weight loss. Systematic vitamin and calcium supplementation, as well as follow-up by DEXA scan seems appropriate, with systematic DEXA scan pre- and post-surgery, and annually thereafter until weight has stabilized.


Disclosure: M. Geoffroy, None; I. Lambrecht, None; J. Chrusciel, None; I. Gaubil-Kaladjian, None; A. Diaz-Cives, None; J. P. Eschard, None; J. H. Salmon, None.

To cite this abstract in AMA style:

Geoffroy M, Lambrecht I, Chrusciel J, Gaubil-Kaladjian I, Diaz-Cives A, Eschard JP, Salmon JH. Impact of Bariatric Surgery on Bone Mineral Density : Observational Study of 110 Patients Followed up in a Specialised Centre for the Treatment of Obesity in France [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/impact-of-bariatric-surgery-on-bone-mineral-density-observational-study-of-110-patients-followed-up-in-a-specialised-centre-for-the-treatment-of-obesity-in-france/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-bariatric-surgery-on-bone-mineral-density-observational-study-of-110-patients-followed-up-in-a-specialised-centre-for-the-treatment-of-obesity-in-france/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology